A cytokine mixture of GM-CSF and IL-3 that induces a neuroprotective phenotype of microglia leading to amelioration of (6-OHDA)-induced Parkinsonism of rats

Dopamine (DA) agonists are widely used as primary treatments for Parkinson's disease. However, they do not prevent progressive degeneration of dopaminergic neurons, the central pathology of the disease. In this study, we found that subcutaneous injection of a cytokine mixture containing granulo...

Descripción completa

Detalles Bibliográficos
Autores principales: Choudhury, Mohammed Emamussalehin, Sugimoto, Kana, Kubo, Madoka, Nagai, Masahiro, Nomoto, Masahiro, Takahashi, Hisaaki, Yano, Hajime, Tanaka, Junya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Inc 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3217672/
https://www.ncbi.nlm.nih.gov/pubmed/22398979
http://dx.doi.org/10.1002/brb3.11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3217672/
https://www.ncbi.nlm.nih.gov/pubmed/22398979
http://dx.doi.org/10.1002/brb3.11

Ejemplares similares